No clear association between Paxlovid and COVID-19 rebound, FDA says
(NEW YORK) -- A U.S. Food and Drug Administration analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid and illness rebound, the FDA said in a new report.Rebound rates are around the same in people who took the drug and those... Read More.